Researchers describe a method to quickly program patient-derived T cells using DNA-carrying nanoparticles with genes encoding disease-specific chimeric antigen receptors (CARs), so that they can combat tumour cells once they are reinfused, thereby bringing about long-term disease remission.

See the source article by following the link below:
Researchers describe a method to quickly program patient-derived T cells using DNA-carrying nanoparticles with genes encoding disease-specific chimeric antigen receptors (CARs), so that they can combat tumour cells once they are reinfused, thereby bringing about long-term disease remission.